Purchases and Sales Made in Q4 2024 in Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM) during Q4 2024. The information is specifically focused on institutions that hold shares of Eliem Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
19.3K+ 164.52% |
$79.2K - $104K
|
31K
$127K
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
14.3KNew |
$58.6K - $77.3K
|
14.3K
$58.6K
|
|
Jan 23, 2025
Q4 2024
|
Chicago Partners Investment Group LLC
|
BUY
|
- |
4.73K+ 27.87% |
$19.4K - $25.6K
|
21.7K
$89.2K
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
4.1K+ 14.77% |
$16.8K - $22.2K
|
31.8K
$131K
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
BUY
|
- |
2.24KNew |
$9.21K - $12.1K
|
2.24K
$9.21K
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
1.33KNew |
$5.47K - $7.21K
|
1.33K
$5.47K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
227New |
$933 - $1.23K
|
227
$933
|